Apogee Therapeutics, Inc. logo APGE - Apogee Therapeutics, Inc.

Inactive Ticker APGE is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 2
HOLD 12
SELL 0
STRONG
SELL
0
| PRICE TARGET: $130.92 DETAILS
HIGH: $140.00
LOW: $89.00
MEDIAN: $135.00
CONSENSUS: $130.92
DOWNSIDE: 3.07%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0.4 (0.4) 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 (0.4) 0.4 (0.4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 67.3 60.8 58.4 54.2 55.7 46.4 60.2 45.7 33.2 28.7 29.0 17.1 13.9 8.5 12.2 9.9 1.4 4.2
SG&A Expenses 24.3 21.5 20.1 17.1 17.1 16.6 15.7 13.0 10.9 9.5 8.2 7.2 4.9 4.2 1.9 0.6 0.4 0.1
Other Expenses 4.4 0 (0.1) (0.4) 0.3 0.1 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 96.0 82.4 78.5 70.9 73.2 63.1 75.9 58.7 44.1 38.2 37.2 24.3 18.9 12.7 14.1 10.5 1.8 4.3
Operating Income
Operating Income (96.0) (82.8) (78.1) (71.3) (73.2) (63.1) (75.9) (58.7) (44.1) (38.2) (37.2) (24.3) (18.9) (12.7) (14.1) (10.5) (1.8) (4.3)
Interest Expense 1.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.2 0 0
Interest Income 11.8 8.7 (21.3) 6.3 7.1 7.8 8.7 9.7 10.3 6.1 5.4 3.5 0 0.1 0.1 0 0 0
Profitability
EBITDA (83.8) (73.6) (68.9) (64.6) (65.6) (55.0) (67.1) (49.0) (33.8) (32.1) (31.7) (20.8) 0 0.1 (14.0) 0 0 0
EBIT (84.2) (74.0) (69.3) (65.0) (66.0) (55.3) (67.2) (49.0) (33.8) (32.1) (31.7) (20.8) (18.9) (12.5) (14.0) (10.5) (1.8) (4.3)
Income Before Tax (85.8) (74.0) (69.3) (65.0) (66.0) (55.3) (67.2) (49.0) (33.8) (32.1) (31.7) (20.8) (18.9) (12.5) (14.0) (19.7) (1.8) (4.3)
Income Tax Expense 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0 0 0 0 0 0 0 0 0 0 0
Net Income (85.9) (74.1) (69.4) (65.0) (66.1) (55.3) (67.2) (49.0) (33.8) (32.1) (31.7) (20.8) (18.9) (12.5) (14.0) (19.7) (1.8) (4.3)
Per Share Data
EPS (Basic) -1.14 -1.06 -1.03 -1.11 -1.13 -0.95 -1.22 -0.86 -0.60 -0.64 -0.63 -0.41 -0.37 -0.25 -0.28 -0.39 -0.04 -0.09
EPS (Diluted) -1.14 -1.06 -1.03 -1.11 -1.13 -0.95 -1.22 -0.86 -0.60 -0.64 -0.63 -0.41 -0.37 -0.25 -0.28 -0.39 -0.04 -0.09
Shares Outstanding 75.4 69.7 60.7 58.8 58.4 58.2 55.2 56.8 56.5 50.2 50.7 50.7 50.7 50.7 50.7 50.7 50.7 50.7
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4
Current Assets
Cash & Cash Equivalents 105.6 451.8 131.5 107.9 124.2 106.9 141.8 118.8 307.3 485.5 118.3 188.3 125.1 141.3 151.9
Short-Term Investments 866.4 608.1 598.6 419.4 381.2 406.4 378.9 407.3 368.9 330.7 277.1 234.6 0 0 0
Net Receivables 0 7.3 6.0 4.5 4.1 5.0 4.7 4.8 0 0 1.2 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0 1.2 0.6 0.9 1.0 0.6 1.7 0.4 3.4 2.7 0 1.4 4.4 0.5 0.1
Total Current Assets 991.7 1,073.8 741.4 540.1 516.1 521.5 529.7 534.5 681.9 820.6 398.4 426.4 130.7 142.0 152.1
Non-Current Assets
Property, Plant & Equipment 11.5 13.0 14.4 15.7 17.0 17.2 13.3 13.5 4.9 2.6 2.6 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 321.9 0 0 61.6 115.8 168.1 210.4 227.7 113.4 0.3 0.3 0 0 0 0
Other Non-Current Assets 10.6 206.9 181.4 8.7 8.9 7.3 0.5 0.5 0.5 0.1 0.1 0.2 0 0 0
Total Non-Current Assets 344.1 219.9 195.8 86.1 141.7 192.6 224.2 241.8 118.8 3.1 3.0 0.2 0 0 0
Total Assets 1,335.8 1,293.7 937.1 626.2 657.8 714.2 754.0 776.3 800.7 823.7 401.4 426.4 130.7 142.0 152.1
Current Liabilities
Account Payables 3.1 1.2 1.2 0.4 5.7 2.4 1.1 2.2 5.5 4.3 2.1 1.2 11.1 1.0 0.4
Short-Term Debt 0 0 0 0 4.0 4.0 3.2 2.9 1.7 1.1 1.1 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 0 6.3 3.7 12.7 13.7 21.3 22.4 20.6 13.4 13.8 17.1 13.7 0.9 0.3 0
Total Current Liabilities 37.5 33.0 27.9 34.0 31.6 33.0 28.6 32.6 24.6 21.6 20.6 17.2 17.6 11.2 10.0
Non-Current Liabilities
Long-Term Debt 0 4.9 5.3 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 99.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Non-Current Liabilities 103.7 4.9 5.3 5.8 6.8 7.8 8.6 9.3 2.4 0.6 0.9 0 0 0 0
Total Liabilities 141.2 37.9 33.3 39.8 38.4 40.8 37.2 41.9 27.0 22.2 21.5 17.2 17.6 11.2 10.0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 6.8 2.3 2.3
Retained Earnings (721.7) (635.9) (561.8) (492.4) (427.4) (361.3) (305.9) (238.7) (189.7) (155.9) (123.8) (92.0) (71.2) (52.3) (39.8)
Accumulated Other Comprehensive Income (2.5) (0.7) 1.1 1.0 0.7 1.1 0.9 3.3 (0.3) (0.2) 0.3 0.1 4.5 3.4 2.1
Total Stockholders' Equity 1,194.6 1,255.8 903.9 586.3 619.4 673.4 716.8 734.4 773.6 801.5 379.9 409.2 113.1 130.8 142.1
Total Liabilities & Equity 1,335.8 1,293.7 937.1 626.2 657.8 714.2 754.0 776.3 800.7 823.7 401.4 426.4 130.7 142.0 152.1
Debt Metrics
Total Debt 6.8 8.0 8.8 9.9 10.8 11.8 11.8 12.1 4.1 1.8 2.0 0 0 0 0
Net Debt (98.7) (443.8) (122.7) (98.1) (113.3) (95.1) (130.0) (106.6) (303.2) (483.7) (116.3) (188.3) (125.1) (141.3) (151.9)
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1
Operating Activities
Net Income (85.9) (74.1) (69.4) (65.0) (66.1) (55.3) (67.2) (49.0) (33.8) (32.1) (31.7) (20.8) (18.9) (12.5) (14.0) (19.7) (1.8) (4.3)
Depreciation & Amortization 0.4 0.4 0.4 0.4 0.4 0.2 0.1 0.0 0.0 0.0 0 0 18.9 12.7 0 10.5 1.8 4.3
Stock-Based Compensation 16.7 17.2 11.9 11.9 11.3 11.1 7.6 5.8 5.7 4.2 2.2 1.5 1.1 1.3 2.1 0 0 0
Change in Working Capital (8.8) 1.5 (4.9) (0.8) (6.8) (2.9) (6.0) 3.7 1.5 (1.3) 2.5 (0.3) 3.2 0.7 2.1 3.3 1.8 2.6
Other Non-Cash Items 6.2 (0.6) (0.8) (0.7) (0.8) (1.5) (2.2) (3.1) (2.8) (2.4) (2.8) (0.2) (18.9) (12.7) 0.6 (1.4) (1.8) (2.6)
Operating Cash Flow (71.4) (55.6) (62.7) (54.3) (62.0) (48.5) (67.7) (42.5) (29.3) (31.6) (29.8) (19.9) (14.6) (10.6) (9.2) (7.2) 0 0
Investing Activities
Capital Expenditure 0 0 (0.1) 0 (0.8) (4.3) 0.0 (0.8) (0.1) (0.4) (0.2) 0 0 0 0 0 0 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (552.8) (183.2) (389.1) (107.6) (47.4) (98.2) (60.6) (236.0) (227.0) (125.9) (69.5) (234.2) 0 0 0 0 0 0
Sales/Maturities of Investments 170.9 147.9 100.5 125.6 126.3 115.5 107.0 90.4 78.3 74.5 30 0 0 0 0 0 0 0
Other Investing Activities 0.0 0 0 0 0 0 0 0 0 0 (234.2) 0 0 0 0 0 0 0
Investing Cash Flow (381.9) (35.3) (288.6) 17.9 78.1 13.0 46.4 (146.4) (148.7) (51.7) (273.9) (234.2) 0 0 0 0 0 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 98.8 0 0 0 0 0 0 0 0 0.0 0 1.7 (1.7) 0 168.3 0 0 0
Financing Cash Flow 107.0 411.2 374.9 19.7 1.2 0.6 44.4 0.4 (0.1) 450.5 (0.2) 317.3 (1.7) 0 158.5 4.8 (0.0) 5
Cash Position
Net Change in Cash (346.2) 320.2 23.6 (16.6) 17.3 (34.9) 23.0 (188.5) (178.2) 367.1 (70.0) 63.2 (16.3) (10.6) 149.3 (2.4) 0 0
Cash at Beginning 451.8 131.5 107.9 124.5 107.2 142.1 119.1 307.6 485.5 118.3 188.3 125.1 141.3 151.9 2.6 5.0 0 0
Cash at End 105.6 451.8 131.5 107.9 124.5 107.2 142.1 119.1 307.3 485.5 118.3 188.3 125.1 141.3 151.9 2.6 0 0
Free Cash Flow (71.4) (55.6) (62.8) (54.3) (62.8) (52.8) (67.7) (43.3) (29.4) (32.0) (29.9) (19.9) (14.6) (10.6) (9.2) (7.2) 0 0
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 (0.4) 0.4 (0.4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (96.0) (82.8) (78.1) (71.3) (73.2) (63.1) (75.9) (58.7) (44.1) (38.2) (37.2) (24.3) (18.9) (12.7) (14.1) (10.5) (1.8) (4.3)
Net Income (85.9) (74.1) (69.4) (65.0) (66.1) (55.3) (67.2) (49.0) (33.8) (32.1) (31.7) (20.8) (18.9) (12.5) (14.0) (19.7) (1.8) (4.3)
EPS (Diluted) -1.14 -1.06 -1.03 -1.11 -1.13 -0.95 -1.22 -0.86 -0.60 -0.64 -0.63 -0.41 -0.37 -0.25 -0.28 -0.39 -0.04 -0.09
Balance Sheet
Cash & Equivalents 105.6 451.8 131.5 107.9 124.2 106.9 141.8 118.8 307.3 485.5 118.3 188.3 125.1 141.3 151.9
Total Assets 1,335.8 1,293.7 937.1 626.2 657.8 714.2 754.0 776.3 800.7 823.7 401.4 426.4 130.7 142.0 152.1
Total Debt 6.8 8.0 8.8 9.9 10.8 11.8 11.8 12.1 4.1 1.8 2.0 0 0 0 0
Stockholders' Equity 1,194.6 1,255.8 903.9 586.3 619.4 673.4 716.8 734.4 773.6 801.5 379.9 409.2 113.1 130.8 142.1
Cash Flow
Operating Cash Flow (71.4) (55.6) (62.7) (54.3) (62.0) (48.5) (67.7) (42.5) (29.3) (31.6) (29.8) (19.9) (14.6) (10.6) (9.2) (7.2) 0 0
Capital Expenditure 0 0 (0.1) 0 (0.8) (4.3) 0.0 (0.8) (0.1) (0.4) (0.2) 0 0 0 0 0 0 0
Free Cash Flow (71.4) (55.6) (62.8) (54.3) (62.8) (52.8) (67.7) (43.3) (29.4) (32.0) (29.9) (19.9) (14.6) (10.6) (9.2) (7.2) 0 0